Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of ß-catenin signaling. (2017)
Attributed to:
Regulation of Wnt and calcium signalling by the Parkinson's disease protein LRRK2
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13024-017-0153-4
PubMed Identifier: 28103901
Publication URI: http://europepmc.org/abstract/MED/28103901
Type: Journal Article/Review
Volume: 12
Parent Publication: Molecular neurodegeneration
Issue: 1
ISSN: 1750-1326